octreotide acetate
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
25 FDA-registered drug labelers
Assia Chemical Industries Ltd - Teva Tech Site
Aurobindo Pharma Limited
Bachem AG
BACHEM AMERICAS, INC.
BCN PEPTIDES SA
Chemical & Biopharmaceutical Laboratories of Patras Single Member S.A.
Chengdu Shengnuo Biopharm Co. Ltd.
FRESENIUS KABI IPSUM SRL
Fresenius Kabi USA, LLC
Gland Pharma Limited
GLENMARK PHARMACEUTICALS INC., USA
Hainan Shuangcheng Pharmaceuticals Co., Ltd.
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Hikma Pharmaceuticals USA Inc.
LSNE, Inc.
Matrix Pharmacorp Private Limited
Meitheal Pharmaceuticals, Inc.
Mylan Institutional LLC
Novartis Pharmaceuticals Corporation
PolyPeptide Laboratories, Pvt. Ltd.
Sagent Pharmaceuticals
ScinoPharm Taiwan Ltd.
Sinopep-Allsino Biopharmaceutical Co., Ltd.
Sterling Pharma Solutions Limited
SUN PHARMACEUTICAL INDUSTRIES, INC.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 4 drug and cosmetic product listings (FDA).
- •Octreotide Acetate
- •Bynfezia Pen
- •Octreotide
- •Sandostatin
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS79517-01-4
PubChem CID155804637
DTXSIDDTXSID901027488
FormulaC53H74N10O14S2
Mol. Weight1139.3 g/mol
SMILESCC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O.CC(=O)O.CC(=O)O
Data Sources
1558046372026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/octreotide acetate/cids/JSON
Archive: data/sources/pubchem_name/octreotide acetate.json
CAS 79517-01-42026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
bulk match2026-04-07
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json